As federal policymakers weigh potential changes to how biomedical research is funded and regulated in the United States, a ...

The Alberta Children’s Hospital is hoping to raise funds to purchase new technology that will help pediatric Ear, Nose and Throat surgeons reduce the risks involved with surgeries that occur within ...

In a pine forest on Michigan’s Upper Peninsula, the only active nickel mine in the US is nearing the end of its life. At a ...

Alejandro Weinstein, Chairman of Pluri, shares insights on the future of biotechnology and cell-based therapies. Weinstein ...

Italy marked a significant milestone at Web Summit Qatar 2026 with its first ever institutional participation, underscoring ...

Eisai will now take ownership of the Japanese rights to Henlius' differentiated anti-PD-1 therapy, Hetronifly (serplulimab).

European biotechs continue to face a demanding investment climate characterised by investor caution. As a result, many are ...

He joins a company that on Jan. 26 announced Michael Iskra as its new CEO, succeeding Arnon Chait, who has held the title since he co-founded the company in 2013. Chait now has the title of chief ...

Major reforms to the United Kingdom’s national research funding agency are aimed at boosting the nation's economy.

While the fears about the impact of AI pummel software stocks, many leading industrial and biotech companies are seeing huge ...

Kos Biotechnology Partners ("Kos"), a global life sciences investment firm, today announced the closing of a financing round in Epikast, a premier provider of technology-enabled commercial and ...

Find research and technology infrastructures that provide resources and services to conduct research and foster innovation in ...